Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Jing Qiu1, Jun Guo2, Liang Liu1

  • 1Department of Neurology, General Hospital of Northern Theater Command, Shenyang, Liaoning Province, China.

Neural Regeneration Research
|June 7, 2023
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endovascular Thrombectomy versus Medical Management in Patients Presenting Beyond 24 Hours of Last Known Well and With FLAIR Vascular Hyperintensities-DWI Mismatch.

World neurosurgery·2026
Same author

Endovascular Thrombectomy Versus Best Medical Management in Patients With Large Vessel Occlusion Stroke Presenting Beyond 24 Hours: Results From the TRACK-LVO Late Multicenter Cohort.

Stroke (Hoboken, N.J.)·2026
Same author

Efficacy and Safety of Adjunctive Cenobamate in Chinese Participants with Focal Seizure.

Advances in therapy·2025
Same author

Correction to "Functional Outcomes of Human Urinary Kallindinogenases in Treatment of Acute Ischemic Stroke".

Stroke·2025
Same author

Case Report: T-Dxd plus bevacizumab in a patient with brain metastases from rectal cancer with HER2 amplification.

Frontiers in oncology·2025
Same author

Functional Outcomes of Human Urinary Kallindinogenases in Treatment of Acute Ischemic Stroke.

Stroke·2025
Same journal

Corrigendum: Neurodegenerative diseases and immune system: From pathogenic mechanism to therapy.

Neural regeneration research·2026
Same journal

Injury and repair in limb deformities associated with peripheral neuropathy: Visualization analyses of research trends and hotspots.

Neural regeneration research·2026
Same journal

Circulating exosomes convey the cognitive benefits of Tai Chi: The role of miR-625-5p in prefrontal remodeling and therapeutic potential.

Neural regeneration research·2026
Same journal

Induced neural stem cells in neuroregeneration: Progress and clinical prospects.

Neural regeneration research·2026
Same journal

Locus coeruleus-norepinephrine system dysfunction: A new concept in cognitive aging and neurodegenerative diseases.

Neural regeneration research·2026
Same journal

The casual explanations of non-coding risk variants in Alzheimer's disease: From single mutation to lipid dysregulation.

Neural regeneration research·2026
See all related articles

Silencing Vav1 reduces brain damage after stroke by inhibiting microglial activation and the NLRP3 inflammasome. This finding offers a potential therapeutic target for cerebral ischemia/reperfusion injury.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are key players in the central nervous system's inflammatory response to cerebral ischemia.
  • Vav guanine nucleotide exchange factor 1 (Vav1) is linked to microglial activation, but its role in cerebral ischemia/reperfusion injury is not fully understood.

Purpose of the Study:

  • To investigate the role of Vav1 in the inflammatory response following cerebral ischemia/reperfusion injury.
  • To determine if targeting Vav1 can mitigate brain damage and neurological deficits.

Main Methods:

  • Used a rat model of middle cerebral artery occlusion/reperfusion and an in vitro oxygen-glucose deprivation/reoxygenation model of BV-2 microglia.
  • Measured Vav1 levels, infarct volume, brain water content, neuronal apoptosis, and neurological function.
Keywords:
NLRP3 inflammasomeVav1apoptosiscerebral ischemia/reperfusioninflammatory cytokinesmicrogliamicroglial activationmiddle cerebral artery occlusionneuroprotectionoxygen-glucose deprivation/reoxygenation

Related Experiment Videos

  • Assessed microglial activation, NLRP3 inflammasome activation, and inflammatory factor expression.

    • Main Results:

    • Vav1 levels were elevated in both in vivo and in vitro models of cerebral ischemia/reperfusion.
    • Silencing Vav1 significantly reduced infarct volume, brain water content, neuronal apoptosis, and improved neurological function.
    • Vav1 downregulation inhibited microglial activation, NLRP3 inflammasome activation, and inflammatory factor expression in the ischemic penumbra.

    Conclusions:

    • Vav1 plays a critical role in mediating the inflammatory response and neuronal damage after cerebral ischemia/reperfusion.
    • Inhibiting Vav1 attenuates brain injury by suppressing microglial activation and the NLRP3 inflammasome.
    • Targeting Vav1 presents a promising therapeutic strategy for treating cerebral ischemia/reperfusion injury.